# Si-Bone (SIBN) Stock Price, News & Analysis
Canonical URL: https://biopharmsignal.com/company/SIBN
## Company Profile
- Ticker: SIBN
- Exchange: NASDAQ
- Sector: Biopharma
- Location: United States
## Stock Data
- Close: 18.04 USD
- Market cap: 621333454.83 USD
- Last updated: 2026-08-05
## Business Overview
### Spinopelvic Procedural Solutions
SI-BONE is a global medical-device company developing procedural solutions for patients with compromised bone, with a particular focus on the sacropelvic and spinopelvic anatomy.
### iFuse Technology Platform
Its portfolio is built around the iFuse family of implants and instruments. Products include solutions for sacroiliac-joint fusion, pelvic trauma and complex spinal-fusion procedures, including iFuse TORQ, iFuse TORQ TNT and iFuse Bedrock Granite. SI-BONE supports adoption through physician education, dedicated sales territories and procedure-specific product development. The company sells in the United States and is expanding selected products into international markets.
## Why The Stock Is Moving

As of Aug 5, 2026, SIBN closed down 2.17% at $18.04. No new same-company headline was identified in the current news window.

## Future Catalysts

- Si-Bone is heading into a more important stretch around Highlights and all comparisons are to the prior year period. Management's latest framing highlights continued work around Highlights and all comparisons are to the prior year period and the next company-specific development update. The stock is likely to react most to whether those milestones keep moving without a reset.

## Recent News
- 2026-08-03 20:09 EST — [SI-BONE, Inc. Reports Financial Results for the Second Quarter 2026 and Raises 2026 Guidance](https://biopharmsignal.com/news/SIBN/si-bone-inc-reports-financial-results-for-the-second-quarter-2026-and-raises-202-cc17b0e9) — Source: Si-Bone
- 2026-07-20 20:09 EST — [SI-BONE To Report Second Quarter 2026 Financial Results on August 3, 2026](https://biopharmsignal.com/news/SIBN/si-bone-to-report-second-quarter-2026-financial-results-on-august-3-2026-5bb93a97) — Source: Si-Bone
- 2026-06-04 20:09 EST — [SI-BONE To Present at Truist Securities 2026 MedTech Conference on June 16, 2026](https://biopharmsignal.com/news/SIBN/si-bone-to-present-at-truist-securities-2026-medtech-conference-on-june-16-2026-78a98d1b) — Source: Si-Bone
- 2026-05-11 20:09 EST — [SI-BONE, Inc. Reports Financial Results for the First Quarter 2026 and Raises 2026 Guidance](https://biopharmsignal.com/news/SIBN/si-bone-inc-reports-financial-results-for-the-first-quarter-2026-and-raises-2026-guidance) — Source: Si-Bone
- 2026-04-30 20:09 EST — [SI-BONE To Present at BofA Securities 2026 Healthcare Conference on May 12, 2026](https://biopharmsignal.com/news/SIBN/si-bone-to-present-at-bofa-securities-2026-healthcare-conference-on-may-12-2026) — Source: Si-Bone